Zobrazeno 1 - 10
of 685
pro vyhledávání: '"•Intravenous immunoglobulin (IVIG)"'
Quality of medicinal maltose as a excipient in the production of blood products: a comparative study
Publikováno v:
Zhongguo shuxue zazhi, Vol 37, Iss 5, Pp 580-585 (2024)
Objective To comprehensively compare the quality and filtration efficiency of medicinal maltose between two domestic manufacturers(B, C) and one foreign manufacturer(A), compare their product quality as an excipient for intravenous immunoglobulin(IVI
Externí odkaz:
https://doaj.org/article/639d3f6b344e49ae98180d1317535a62
Autor:
Michelle Patrick Olivarez, Jarod Williams, Nutnapong Udomteerasuwat, Sarah Corner, Christopher Byers
Publikováno v:
Frontiers in Veterinary Science, Vol 11 (2024)
A 10-year-old spayed female Dachshund presented with abdominal pain and generalized severe ileus. An exploratory laparotomy was performed, confirming a severe ileus of undetermined origin. Multiple intestinal biopsy results confirmed acute intestinal
Externí odkaz:
https://doaj.org/article/e3fab5546c8744aa89fdf620ac9206f5
Publikováno v:
Zhongguo shuxue zazhi, Vol 36, Iss 12, Pp 1102-1106 (2023)
Objective To develop methods to display the IgG autoantibody repertoire of intravenous immunoglobulin (IVIG) products, analyze the different types of antibodies and study the diversity of IgG autoantibody in 4 IVIG preparations from different Chinese
Externí odkaz:
https://doaj.org/article/fe3e5bfd424b4d51830a82968f4dea76
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionNon-Hodgkin’s lymphoma (NHL) encompasses a diverse group of lymphoma subtypes with a wide range in disease course. Previous studies show that hypogammaglobulinemia in treatment-naïve patients is associated with poorer survival in high
Externí odkaz:
https://doaj.org/article/85444e82a0594c84b0ab540f6faf24cd
Autor:
Archan Sil, Suprit Basu, Vibhu Joshi, Rakesh Kumar Pilania, Sangeetha Siniah, Deepti Suri, Amit Rawat, Surjit Singh
Publikováno v:
Frontiers in Pediatrics, Vol 12 (2024)
Immunoglobulins (Ig) were used as a therapeutic modality for the first time in a patient with X-linked agammaglobulinemia in 1952 by Colonel Ogden Bruton, decades before the molecular mechanisms causing the disease were unraveled. In many autoimmune
Externí odkaz:
https://doaj.org/article/8e753cbeee0e490cbc293af466f393a8
Publikováno v:
Frontiers in Molecular Neuroscience, Vol 16 (2023)
Externí odkaz:
https://doaj.org/article/772567f03a3f430fbbfc54c1a12ead70
Publikováno v:
Zhongguo shuxue zazhi, Vol 36, Iss 4, Pp 279-284 (2023)
Objective To investigate the effects of intravenous immunoglobulin (IVIG) on oxaliplatin-induced chemotherapy injury in mice. Methods Fifty-one wild-type male BALB/c mice aged 6-8 weeks were randomly divided into three groups: 1) the control group; 2
Externí odkaz:
https://doaj.org/article/4268ae27c64f4b07840175b3c637f124
Publikováno v:
Frontiers in Molecular Neuroscience, Vol 16 (2023)
The immune system has a role in neuropathic pain which includes autoimmune mechanisms (e.g., autoantibodies). Clinical studies have identified a number of conditions where neuropathic pain is common and that are associated with autoantibodies targeti
Externí odkaz:
https://doaj.org/article/1032ad353b53463b9ebccf0fc06bc25d
Autor:
Farahnoosh Farnood, Hamed Valizadeh, Khalil Ansarin, Sepideh Zununi Vahed, Seyyed Sina Hejazian, Armin Sadeghi, Leila Namvar, Farid Rashidi, Seyyedeh Mina Hejazian, Mohammadreza Ardalan, Akbar Sharifi
Publikováno v:
مجله پزشکی دانشگاه علوم پزشکی تبریز, Vol 44, Iss 5, Pp 403-415 (2022)
Background. COVID-19 disease is the cause of daily morbidity and mortality worldwide due to its high transmissibility and pathogenicity. To date, intravenous immunoglobulin (IVIg) injection has been used as one of the various treatments for this dise
Externí odkaz:
https://doaj.org/article/49513c224cfd49e79dd1f72d5a3ba813
Autor:
Rajiv Mallick, Geneviève Solomon, Paul Bassett, Xiang Zhang, Palak Patel, Oleksandra Lepeshkina
Publikováno v:
Allergy, Asthma & Clinical Immunology, Vol 18, Iss 1, Pp 1-20 (2022)
Abstract Background Understanding the impact of different immunoglobulin (Ig) infusion methods (intravenous [IVIg] and subcutaneous [SCIg]) upon treatment experience can potentially facilitate optimization of patient outcomes. Here, the perspective o
Externí odkaz:
https://doaj.org/article/8e278443240d4b07b9566a497be7d035